Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral L-carnitine for liver enzymes in children with ALL
IRCT20201107049296N2Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levocarnitine in acute lymphoblastic leukemia (ALL), sponsored by Iran University of Medical Sciences. Primary endpoint: Change in liver enzymes. Started Sep 2023; status: completed.
02
Drugs
levocarnitine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on IRCT20201107049296N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201107049296N2.